HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASCLETIS-B

12.390

+0.3903.25%

Volume:2.36M

Turnover:29.04M

Market Cap:12.29B

PE:-37.01

High:12.530

Open:11.960

Low:11.960

Close:12.000

52wk High:18.750

52wk Low:2.820

Shares:992.00M

HK Float Shares:992.00M

Volume Ratio:0.79

T/O Rate:0.24%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.335

ROE:-12.77%

ROA:-12.32%

PB:5.91

PE(LYR):-37.01

PS:4666.52

Loading ...

Overview Company News Filings

Ascletis Pharma's Autoimmune Disease Drug Trial Shows Positive Topline Results

MT Newswires Live

Ascletis Announces Positive Topline Results From U.S. Phase I Study of Asc50, a Potential Best-in-Class Oral Small Molecule Il-17 Inhibitor

THOMSON REUTERS

Ascletis Pharma Inc - Asc50 Safe and Well Tolerated at All Dose Levels

THOMSON REUTERS

ASCLETIS-B (01672): Positive Topline Results from US Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor

Ascletis Pharma Reports Positive Phase I Results for Oral IL-17 Inhibitor ASC50

Hong Kong Stocks Open Lower: Hang Seng Index Down 1%, Pharmaceutical Sector Leads Declines with ASCLETIS-B (01672) Dropping Over 5%

ASCLETIS-B (01672) Repurchases 300,000 Shares for Approximately HK$4.37 Million on December 12

Ascletis Pharma Repurchases 300,000 Shares at HK$14.8 Each, Files Disclosure with HKEX

Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (Asc40), a First-in-Class Fasn Inhibitor for Acne Treatment

THOMSON REUTERS

ASCLETIS-B (01672): First-in-Class FASN Inhibitor Denifanstat (ASC40) NDA for Acne Treatment Accepted by China NMPA

China NMPA Accepts New Drug Application for Ascletis Pharma's Denifanstat for Acne Treatment

Ascletis Pharma Inc - Nmpa Acceptance of Nda for Denifanstat

THOMSON REUTERS

Shares of Chinese Drugmaker Ascletis Rise on Weight-Loss Drug Results

Citi: Ascletis-B's ASC30 Phase IIa Data Further Demonstrates Best-in-Class Potential, Reiterates "Buy/High Risk" Rating

Hong Kong Stocks Narrowly Fluctuate; ASCLETIS-B Surges Over 23% on Positive News

HK Movers | Biomedical Stocks Jump With Ascletis Pharma up 21%, Sirnaomics up 11%

Tiger Newspress

HK Movers | Ascletis Pharma Surges as ASC30 Shows Positive Top-Line Results in 13-Week Phase 2 Obesity Trial

Tiger Newspress

Ascletis Pharma Inc - Asc30 Tablets Show Significant Dose-Dependent Weight Reductions

THOMSON REUTERS

Ascletis' Oral Small Molecule Glp-1, Asc30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% With Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase Ii Study in Participants With Obesity or Overweight

THOMSON REUTERS

Ascletis Pharma Inc - No Hepatic Safety Signal Observed in Asc30 Study

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/01672/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01672","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01672\",,,,,undefined,":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"ASCLETIS-B","latestPrice":12.39,"timestamp":1767773290003,"preClose":12,"halted":0,"volume":2358736,"delay":0,"floatShares":992000000,"shares":992000000,"eps":-0.33475406959664167,"marketStatus":"Closed","change":0.39,"latestTime":"01-07 16:08:10","open":11.96,"high":12.53,"low":11.96,"amount":29043650,"amplitude":0.0475,"askPrice":12.4,"askSize":22000,"bidPrice":12.39,"bidSize":124000,"shortable":3,"etf":0,"ttmEps":-0.2955773548836811,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1767835800000},"marketStatusCode":5,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":12,"openAndCloseTimeList":[[1767749400000,1767758400000],[1767762000000,1767772800000]],"volumeRatio":0.794668,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01672\",,,,,undefined,":{"symbol":"01672","floatShares":992000000,"roa":"-12.32%","roe":"-12.77%","lyrEps":-0.334754,"volumeRatio":0.794668,"shares":992000000,"dividePrice":0,"high":12.53,"amplitude":0.0475,"preClose":12,"low":11.96,"week52Low":2.82,"pbRate":"5.91","psRate":"4666.52","week52High":18.75,"institutionHeld":0,"latestPrice":12.39,"committee":0.69863,"eps":-0.33475406959664167,"divideRate":0,"volume":2358736,"delay":0,"ttmEps":-0.2955773548836811,"open":11.96,"prevYearClose":11.39,"prevWeekClose":11.52,"prevMonthClose":11.39,"prevQuarterClose":11.39,"fiveDayClose":11.55,"twentyDayClose":13.65,"sixtyDayClose":10.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01672\",params:#limit:5,,,undefined,":[{"date":"2025-08-15","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755221400000,"name":null,"time":"","dateTimestamp":1755187200000,"actualEps":null},{"date":"2025-03-26","symbol":"01672","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"Pre-Market","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-30","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null},{"date":"2024-03-25","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-21","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692581400000,"name":null,"time":"","dateTimestamp":1692547200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01672\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01672\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1749744000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01672\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01672","date":"2026-01-06","current":-41.917961,"percent":0.044715,"low":-62.492237,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"high":-3.060869,"avg":-15.976542,"sd":10.772102,"marketCap":11842659840},"quantilePoints":[{"date":"2021-01-08","current":-25.623114,"twenty":-26.33735,"median":-26.070062,"eighty":-25.606579,"marketCap":3076589600},{"date":"2021-01-15","current":-26.301013,"twenty":-26.257669,"median":-26.058174,"eighty":-25.606579,"marketCap":3153504340},{"date":"2021-01-22","current":-27.687281,"twenty":-26.817021,"median":-26.133868,"eighty":-25.701626,"marketCap":3318321640},{"date":"2021-01-29","current":-25.459845,"twenty":-26.817021,"median":-26.18132,"eighty":-25.701626,"marketCap":3076589600},{"date":"2021-02-05","current":-26.710974,"twenty":-27.144116,"median":-26.500215,"eighty":-25.780011,"marketCap":3208443440},{"date":"2021-02-11","current":-26.94677,"twenty":-27.163157,"median":-26.50182,"eighty":-25.840901,"marketCap":3241406900},{"date":"2021-02-19","current":-29.217648,"twenty":-27.39605,"median":-26.606395,"eighty":-25.934212,"marketCap":3516102400},{"date":"2021-02-26","current":-27.726401,"twenty":-28.252216,"median":-26.780324,"eighty":-26.051041,"marketCap":3329309460},{"date":"2021-03-05","current":-26.695247,"twenty":-28.196164,"median":-26.801757,"eighty":-26.075007,"marketCap":3197455620},{"date":"2021-03-12","current":-27.661035,"twenty":-27.925684,"median":-26.796554,"eighty":-25.934212,"marketCap":3307333820},{"date":"2021-03-19","current":-27.578315,"twenty":-28.013713,"median":-26.946171,"eighty":-26.051041,"marketCap":3296346000},{"date":"2021-03-26","current":-26.684915,"twenty":-27.992927,"median":-26.925194,"eighty":-26.075007,"marketCap":3175479980},{"date":"2021-04-01","current":-12.856888,"twenty":-27.937324,"median":-26.841361,"eighty":-25.906193,"marketCap":3186467800},{"date":"2021-04-09","current":-12.651626,"twenty":-27.902405,"median":-26.79135,"eighty":-25.749374,"marketCap":3142516520},{"date":"2021-04-16","current":-12.515766,"twenty":-27.83964,"median":-26.703111,"eighty":-25.606579,"marketCap":3120540880},{"date":"2021-04-23","current":-12.748275,"twenty":-27.761167,"median":-26.610487,"eighty":-20.3699,"marketCap":3186467800},{"date":"2021-04-30","current":-12.958615,"twenty":-27.702929,"median":-26.546385,"eighty":-12.849963,"marketCap":3252394720},{"date":"2021-05-07","current":-13.875629,"twenty":-27.671533,"median":-26.500215,"eighty":-12.917924,"marketCap":3505114580},{"date":"2021-05-14","current":-13.623513,"twenty":-27.632266,"median":-26.264893,"eighty":-13.033167,"marketCap":3439187660},{"date":"2021-05-21","current":-13.663274,"twenty":-27.599178,"median":-26.114327,"eighty":-13.140261,"marketCap":3450175480},{"date":"2021-05-28","current":-15.770587,"twenty":-27.536493,"median":-26.046286,"eighty":-13.276483,"marketCap":4021542120},{"date":"2021-06-04","current":-14.720056,"twenty":-27.44752,"median":-25.775671,"eighty":-13.355805,"marketCap":3735858800},{"date":"2021-06-11","current":-16.063352,"twenty":-27.383939,"median":-25.742295,"eighty":-13.363408,"marketCap":4076481220},{"date":"2021-06-18","current":-14.31767,"twenty":-27.321052,"median":-25.623114,"eighty":-13.37885,"marketCap":3604004960},{"date":"2021-06-25","current":-15.287624,"twenty":-27.213321,"median":-25.50862,"eighty":-13.470373,"marketCap":3845737000},{"date":"2021-07-02","current":-15.35814,"twenty":-27.20728,"median":-21.095972,"eighty":-13.623513,"marketCap":3856724820},{"date":"2021-07-09","current":-15.855335,"twenty":-27.138398,"median":-16.377335,"eighty":-13.663274,"marketCap":3977590840},{"date":"2021-07-16","current":-14.892058,"twenty":-27.096973,"median":-16.253526,"eighty":-13.686225,"marketCap":3735858800},{"date":"2021-07-23","current":-14.192621,"twenty":-26.97726,"median":-16.035624,"eighty":-13.755247,"marketCap":3560053680},{"date":"2021-07-30","current":-12.791706,"twenty":-26.94677,"median":-15.809995,"eighty":-13.432088,"marketCap":3219431260},{"date":"2021-08-06","current":-12.341273,"twenty":-26.946171,"median":-15.662682,"eighty":-13.226349,"marketCap":3098565240},{"date":"2021-08-13","current":-12.368185,"twenty":-26.904217,"median":-15.576148,"eighty":-12.99939,"marketCap":3109553060},{"date":"2021-08-20","current":-11.921226,"twenty":-26.880965,"median":-15.419458,"eighty":-12.856888,"marketCap":2988687040},{"date":"2021-08-27","current":-9.483763,"twenty":-26.801757,"median":-15.385644,"eighty":-12.791706,"marketCap":3065601780},{"date":"2021-09-03","current":-9.989583,"twenty":-26.79135,"median":-15.321348,"eighty":-12.740344,"marketCap":3230419080},{"date":"2021-09-10","current":-10.099521,"twenty":-26.758891,"median":-15.242013,"eighty":-12.683051,"marketCap":3274370360},{"date":"2021-09-17","current":-9.347674,"twenty":-26.710974,"median":-15.066642,"eighty":-12.561454,"marketCap":3021650500},{"date":"2021-09-24","current":-9.343351,"twenty":-26.698392,"median":-15.042421,"eighty":-12.475139,"marketCap":3021650500},{"date":"2021-09-30","current":-8.973563,"twenty":-26.689048,"median":-14.919568,"eighty":-12.420739,"marketCap":2911772300},{"date":"2021-10-08","current":-9.244464,"twenty":-26.640258,"median":-14.827353,"eighty":-12.337134,"marketCap":2999538360},{"date":"2021-10-15","current":-9.166534,"twenty":-26.60885,"median":-14.642735,"eighty":-12.284716,"marketCap":2976292730},{"date":"2021-10-22","current":-9.46655,"twenty":-26.590594,"median":-14.417378,"eighty":-12.067263,"marketCap":3095773440},{"date":"2021-10-29","current":-9.149748,"twenty":-26.550486,"median":-14.330599,"eighty":-10.167628,"marketCap":2984772960},{"date":"2021-11-05","current":-8.624888,"twenty":-26.516254,"median":-14.241832,"eighty":-9.980119,"marketCap":2818192610},{"date":"2021-11-12","current":-9.42017,"twenty":-26.501178,"median":-13.883402,"eighty":-9.642783,"marketCap":3090742560},{"date":"2021-11-19","current":-9.993809,"twenty":-26.445097,"median":-13.875629,"eighty":-9.639623,"marketCap":3274313120},{"date":"2021-11-26","current":-9.93865,"twenty":-26.337858,"median":-13.67475,"eighty":-9.647662,"marketCap":3257283040},{"date":"2021-12-03","current":-10.40565,"twenty":-26.272117,"median":-13.432088,"eighty":-9.665551,"marketCap":3416642270},{"date":"2021-12-10","current":-10.070825,"twenty":-26.190811,"median":-13.356835,"eighty":-9.665551,"marketCap":3312350560},{"date":"2021-12-17","current":-9.235444,"twenty":-26.118235,"median":-13.082869,"eighty":-9.631582,"marketCap":3035489310},{"date":"2021-12-24","current":-9.813413,"twenty":-26.084896,"median":-12.999709,"eighty":-9.575593,"marketCap":3228535530},{"date":"2021-12-31","current":-10.844012,"twenty":-26.065307,"median":-12.934788,"eighty":-9.578506,"marketCap":3575354860},{"date":"2022-01-07","current":-11.844839,"twenty":-13.746537,"median":-11.844839,"eighty":-10.061407,"marketCap":3890507720},{"date":"2022-01-14","current":-13.898995,"twenty":-13.746537,"median":-12.309572,"eighty":-10.552334,"marketCap":4575150140},{"date":"2022-01-21","current":-16.436478,"twenty":-16.916833,"median":-13.314768,"eighty":-11.444508,"marketCap":5422802660},{"date":"2022-01-28","current":-12.515763,"twenty":-15.891088,"median":-13.294428,"eighty":-11.905461,"marketCap":4118721860},{"date":"2022-02-04","current":-12.918373,"twenty":-15.527494,"median":-13.172133,"eighty":-11.945875,"marketCap":4249129940},{"date":"2022-02-11","current":-13.749623,"twenty":-15.527494,"median":-13.643555,"eighty":-12.107031,"marketCap":4531680780},{"date":"2022-02-18","current":-14.699583,"twenty":-15.230713,"median":-13.762166,"eighty":-12.512113,"marketCap":4868568320},{"date":"2022-02-25","current":-14.401585,"twenty":-15.230713,"median":-13.898995,"eighty":-12.515763,"marketCap":4781629600},{"date":"2022-03-04","current":-15.050437,"twenty":-15.15343,"median":-14.35444,"eighty":-12.745602,"marketCap":4998976400},{"date":"2022-03-11","current":-11.829182,"twenty":-15.076137,"median":-14.197144,"eighty":-12.515763,"marketCap":3923109740},{"date":"2022-03-18","current":-18.160245,"twenty":-15.15343,"median":-14.130354,"eighty":-12.512113,"marketCap":5998771680},{"date":"2022-03-25","current":-23.265801,"twenty":-15.804034,"median":-14.369858,"eighty":-12.515763,"marketCap":5694486160},{"date":"2022-04-01","current":-22.572946,"twenty":-18.160245,"median":-14.63199,"eighty":-12.7161,"marketCap":5531476060},{"date":"2022-04-08","current":-23.715707,"twenty":-21.833142,"median":-14.748151,"eighty":-12.739702,"marketCap":5814026900},{"date":"2022-04-14","current":-21.490504,"twenty":-21.683047,"median":-14.849995,"eighty":-12.849265,"marketCap":5259792560},{"date":"2022-04-22","current":-19.863698,"twenty":-21.600394,"median":-14.955439,"eighty":-12.933785,"marketCap":4770762260},{"date":"2022-04-29","current":-19.590787,"twenty":-21.409116,"median":-15.049314,"eighty":-13.002214,"marketCap":4629486840},{"date":"2022-05-06","current":-17.396263,"twenty":-21.270237,"median":-15.076137,"eighty":-13.110961,"marketCap":4076752500},{"date":"2022-05-13","current":-18.610663,"twenty":-21.20305,"median":-15.230713,"eighty":-13.274087,"marketCap":4283307960},{"date":"2022-05-20","current":-18.632644,"twenty":-20.958324,"median":-15.665764,"eighty":-13.314768,"marketCap":4348536000},{"date":"2022-05-27","current":-17.623136,"twenty":-20.880127,"median":-16.522446,"eighty":-13.630838,"marketCap":4109366520},{"date":"2022-06-02","current":-17.853668,"twenty":-20.492571,"median":-17.233543,"eighty":-13.641012,"marketCap":4185465900},{"date":"2022-06-10","current":-18.161257,"twenty":-19.970095,"median":-17.41371,"eighty":-13.669209,"marketCap":4228951260},{"date":"2022-06-17","current":-17.854023,"twenty":-19.645369,"median":-17.431157,"eighty":-13.717329,"marketCap":4152851880},{"date":"2022-06-24","current":-18.109092,"twenty":-19.371762,"median":-17.63025,"eighty":-13.745249,"marketCap":4228951260},{"date":"2022-06-30","current":-17.673991,"twenty":-19.310985,"median":-17.653236,"eighty":-13.764675,"marketCap":4120237860},{"date":"2022-07-08","current":-18.30801,"twenty":-19.310985,"median":-17.673991,"eighty":-13.849281,"marketCap":4272436620},{"date":"2022-07-15","current":-16.316301,"twenty":-19.289141,"median":-17.666899,"eighty":-13.997737,"marketCap":3772354980},{"date":"2022-07-22","current":-16.540555,"twenty":-19.000023,"median":-17.637365,"eighty":-14.143712,"marketCap":3826711680},{"date":"2022-07-29","current":-15.769476,"twenty":-18.747643,"median":-17.569111,"eighty":-14.282271,"marketCap":3652770240},{"date":"2022-08-05","current":-16.327325,"twenty":-18.677534,"median":-17.396263,"eighty":-14.357524,"marketCap":3772354980},{"date":"2022-08-12","current":-16.540049,"twenty":-18.643914,"median":-17.288694,"eighty":-14.388894,"marketCap":3826711680},{"date":"2022-08-19","current":-16.280106,"twenty":-18.622948,"median":-17.233543,"eighty":-14.502281,"marketCap":3728869620},{"date":"2022-08-26","current":-18.968898,"twenty":-18.789197,"median":-17.288694,"eighty":-14.644506,"marketCap":3815840340},{"date":"2022-09-02","current":-16.867763,"twenty":-18.730307,"median":-17.347726,"eighty":-14.697577,"marketCap":3380986740},{"date":"2022-09-09","current":-16.76889,"twenty":-18.677534,"median":-17.249775,"eighty":-14.757865,"marketCap":3348372720},{"date":"2022-09-16","current":-15.716335,"twenty":-18.64955,"median":-17.115151,"eighty":-14.796788,"marketCap":3109203240},{"date":"2022-09-23","current":-15.015443,"twenty":-18.62618,"median":-16.946014,"eighty":-14.839374,"marketCap":2913519120},{"date":"2022-09-30","current":-15.37826,"twenty":-18.614156,"median":-16.751565,"eighty":-14.921103,"marketCap":2989618500},{"date":"2022-10-07","current":-14.819903,"twenty":-18.606636,"median":-16.630085,"eighty":-14.836542,"marketCap":2880905100},{"date":"2022-10-14","current":-13.000449,"twenty":-18.587919,"median":-16.540555,"eighty":-14.695572,"marketCap":2500408200},{"date":"2022-10-21","current":-13.203919,"twenty":-18.5546,"median":-16.521647,"eighty":-14.34519,"marketCap":2522150880},{"date":"2022-10-28","current":-14.480815,"twenty":-18.46151,"median":-16.451964,"eighty":-14.220761,"marketCap":2761320360},{"date":"2022-11-04","current":-17.728963,"twenty":-18.445575,"median":-16.484507,"eighty":-14.220761,"marketCap":3413600760},{"date":"2022-11-11","current":-16.285217,"twenty":-18.404401,"median":-16.520848,"eighty":-14.319989,"marketCap":3163559940},{"date":"2022-11-18","current":-20.103605,"twenty":-18.5546,"median":-16.540302,"eighty":-14.34519,"marketCap":3891939720},{"date":"2022-11-25","current":-17.886989,"twenty":-18.5546,"median":-16.584302,"eighty":-14.376203,"marketCap":3435343440},{"date":"2022-12-02","current":-19.030264,"twenty":-18.606636,"median":-16.684302,"eighty":-14.417431,"marketCap":3717998280},{"date":"2022-12-09","current":-19.130787,"twenty":-18.629412,"median":-16.76889,"eighty":-14.498534,"marketCap":3772354980},{"date":"2022-12-16","current":-20.667558,"twenty":-18.761338,"median":-16.964223,"eighty":-14.594443,"marketCap":4065881160},{"date":"2022-12-23","current":-24.859641,"twenty":-18.956709,"median":-17.233543,"eighty":-14.695572,"marketCap":4892103000},{"date":"2022-12-30","current":-25.871174,"twenty":-19.083574,"median":-17.249775,"eighty":-14.69858,"marketCap":5153015160},{"date":"2023-01-06","current":-25.12186,"twenty":-19.140053,"median":-17.290439,"eighty":-14.757865,"marketCap":5055173100},{"date":"2023-01-13","current":-24.544401,"twenty":-19.323084,"median":-17.396263,"eighty":-14.796822,"marketCap":5033430420},{"date":"2023-01-20","current":-23.420078,"twenty":-19.652908,"median":-17.543878,"eighty":-14.810698,"marketCap":4761646920},{"date":"2023-01-27","current":-23.468747,"twenty":-19.824386,"median":-17.569111,"eighty":-14.819903,"marketCap":4772518260},{"date":"2023-02-03","current":-24.305158,"twenty":-20.244661,"median":-17.636045,"eighty":-14.865105,"marketCap":4968202380},{"date":"2023-02-10","current":-21.134736,"twenty":-20.667558,"median":-17.653236,"eighty":-14.903098,"marketCap":4294179300},{"date":"2023-02-17","current":-19.716053,"twenty":-20.880127,"median":-17.673991,"eighty":-14.948111,"marketCap":3968039100},{"date":"2023-02-24","current":-17.499248,"twenty":-20.667558,"median":-17.683976,"eighty":-14.962767,"marketCap":3478828800},{"date":"2023-03-03","current":-17.930481,"twenty":-20.549416,"median":-17.681738,"eighty":-14.98647,"marketCap":3587542200},{"date":"2023-03-10","current":-16.312167,"twenty":-16.61243,"median":-16.354707,"eighty":-16.246481,"marketCap":3239659320},{"date":"2023-03-17","current":-15.99321,"twenty":-859.547185,"median":-27.214831,"eighty":-15.236448,"marketCap":3207045300},{"date":"2023-03-24","current":-8.158391,"twenty":-857.733696,"median":-27.194813,"eighty":-15.146534,"marketCap":2957004480},{"date":"2023-03-31","current":-7.55624,"twenty":-856.818296,"median":-27.138398,"eighty":-15.059097,"marketCap":2717835000},{"date":"2023-04-06","current":-7.893805,"twenty":-856.073051,"median":-27.078657,"eighty":-15.049314,"marketCap":2837419740},{"date":"2023-04-14","current":-8.61117,"twenty":-855.930861,"median":-27.005778,"eighty":-15.016535,"marketCap":3098331900},{"date":"2023-04-21","current":-7.829618,"twenty":-853.743672,"median":-26.946633,"eighty":-14.959836,"marketCap":2815677060},{"date":"2023-04-28","current":-7.736069,"twenty":-851.842458,"median":-26.911578,"eighty":-14.890978,"marketCap":2761320360},{"date":"2023-05-05","current":-8.453174,"twenty":-850.368239,"median":-26.887993,"eighty":-14.810698,"marketCap":3022232520},{"date":"2023-05-12","current":-7.654484,"twenty":-844.255875,"median":-26.864581,"eighty":-14.748851,"marketCap":2717835000},{"date":"2023-05-19","current":-7.204671,"twenty":-840.637331,"median":-26.809281,"eighty":-14.567812,"marketCap":2522150880},{"date":"2023-05-25","current":-7.047343,"twenty":-839.945996,"median":-26.786513,"eighty":-14.442753,"marketCap":2456922840},{"date":"2023-06-02","current":-5.913628,"twenty":-835.38621,"median":-26.758553,"eighty":-14.376203,"marketCap":2054683260},{"date":"2023-06-09","current":-5.702832,"twenty":-818.129553,"median":-26.710974,"eighty":-14.315719,"marketCap":1978583880},{"date":"2023-06-16","current":-6.044208,"twenty":-802.117148,"median":-26.699006,"eighty":-14.193526,"marketCap":2086980480},{"date":"2023-06-23","current":-5.845382,"twenty":-785.68443,"median":-26.663692,"eighty":-13.898995,"marketCap":2007320300},{"date":"2023-06-30","current":-5.980535,"twenty":-778.272292,"median":-26.61418,"eighty":-13.87645,"marketCap":2035154520},{"date":"2023-07-07","current":-6.605364,"twenty":-429.563707,"median":-26.606395,"eighty":-13.753995,"marketCap":2243396480},{"date":"2023-07-14","current":-6.997294,"twenty":-301.659425,"median":-26.583832,"eighty":-13.673153,"marketCap":2409856960},{"date":"2023-07-21","current":-6.759426,"twenty":-288.581382,"median":-26.525876,"eighty":-13.629373,"marketCap":2317116240},{"date":"2023-07-28","current":-6.234106,"twenty":-276.345263,"median":-26.501017,"eighty":-13.418778,"marketCap":2134750610},{"date":"2023-08-04","current":-5.879734,"twenty":-267.511133,"median":-26.433729,"eighty":-13.322151,"marketCap":2016749320},{"date":"2023-08-11","current":-5.535688,"twenty":-209.927243,"median":-26.317959,"eighty":-13.137257,"marketCap":1888020640},{"date":"2023-08-18","current":-5.702326,"twenty":-206.412816,"median":-26.285946,"eighty":-13.008751,"marketCap":1930930200},{"date":"2023-08-25","current":-8.437208,"twenty":-153.130438,"median":-26.194028,"eighty":-12.926079,"marketCap":2209842340},{"date":"2023-09-01","current":-8.966812,"twenty":-53.382403,"median":-26.066754,"eighty":-12.827356,"marketCap":2358305400},{"date":"2023-09-08","current":-8.927792,"twenty":-49.491615,"median":-25.991719,"eighty":-12.748779,"marketCap":2320400530},{"date":"2023-09-15","current":-7.693984,"twenty":-47.216764,"median":-25.915129,"eighty":-12.699259,"marketCap":2015229510},{"date":"2023-09-22","current":-7.514168,"twenty":-46.322006,"median":-25.798974,"eighty":-12.601365,"marketCap":1959526400},{"date":"2023-09-29","current":-8.005269,"twenty":-45.602151,"median":-25.742295,"eighty":-12.513573,"marketCap":2091174700},{"date":"2023-10-06","current":-7.794811,"twenty":-44.867875,"median":-25.623114,"eighty":-12.464811,"marketCap":2035223040},{"date":"2023-10-13","current":-7.593854,"twenty":-44.174678,"median":-25.459845,"eighty":-12.377739,"marketCap":1979791440},{"date":"2023-10-20","current":-7.173699,"twenty":-43.742069,"median":-24.944313,"eighty":-12.316404,"marketCap":1867371240},{"date":"2023-10-27","current":-7.332259,"twenty":-43.600883,"median":-24.544401,"eighty":-12.227731,"marketCap":1907826880},{"date":"2023-11-03","current":-7.467694,"twenty":-43.226685,"median":-24.305158,"eighty":-11.9436,"marketCap":1948225750},{"date":"2023-11-10","current":-7.539507,"twenty":-42.611945,"median":-23.686985,"eighty":-11.104028,"marketCap":1966549970},{"date":"2023-11-17","current":-7.348049,"twenty":-42.179625,"median":-23.417707,"eighty":-10.369722,"marketCap":1933897040},{"date":"2023-11-24","current":-7.63362,"twenty":-41.40647,"median":-22.798937,"eighty":-10.175003,"marketCap":2025594830},{"date":"2023-12-01","current":-7.277958,"twenty":-40.622269,"median":-22.111475,"eighty":-10.082303,"marketCap":1939227350},{"date":"2023-12-08","current":-6.705384,"twenty":-39.890302,"median":-21.490504,"eighty":-9.976804,"marketCap":1779442700},{"date":"2023-12-15","current":-6.541665,"twenty":-39.34123,"median":-20.977411,"eighty":-9.850148,"marketCap":1746020070},{"date":"2023-12-22","current":-6.098485,"twenty":-38.040839,"median":-20.549416,"eighty":-9.736195,"marketCap":1626644760},{"date":"2023-12-29","current":-5.677286,"twenty":-37.684082,"median":-20.244661,"eighty":-9.647662,"marketCap":1522372660},{"date":"2024-01-05","current":-5.003084,"twenty":-37.205408,"median":-19.863698,"eighty":-9.579458,"marketCap":1332122880},{"date":"2024-01-12","current":-5.31345,"twenty":-36.743617,"median":-19.590787,"eighty":-9.495308,"marketCap":1415514140},{"date":"2024-01-19","current":-5.871801,"twenty":-36.390552,"median":-19.317006,"eighty":-9.4536,"marketCap":1562111600},{"date":"2024-01-26","current":-6.568447,"twenty":-36.077009,"median":-19.153952,"eighty":-9.378434,"marketCap":1740643600},{"date":"2024-02-02","current":-6.549533,"twenty":-35.939845,"median":-19.030264,"eighty":-9.332778,"marketCap":1733418600},{"date":"2024-02-09","current":-6.6813,"twenty":-35.587972,"median":-18.817772,"eighty":-9.258152,"marketCap":1777000750},{"date":"2024-02-16","current":-7.015472,"twenty":-35.201054,"median":-18.681712,"eighty":-9.243388,"marketCap":1866282560},{"date":"2024-02-23","current":-6.965496,"twenty":-34.904271,"median":-18.584004,"eighty":-9.15982,"marketCap":1843219560},{"date":"2024-03-01","current":-6.578674,"twenty":-34.762406,"median":-18.393775,"eighty":-9.048962,"marketCap":1741943760},{"date":"2024-03-08","current":-6.116976,"twenty":-34.291324,"median":-18.358603,"eighty":-8.989107,"marketCap":1620412800},{"date":"2024-03-15","current":-6.31372,"twenty":-34.169695,"median":-18.286774,"eighty":-8.966068,"marketCap":1671050700},{"date":"2024-03-22","current":-6.0897,"twenty":-34.007358,"median":-18.165862,"eighty":-8.908417,"marketCap":1610285220},{"date":"2024-03-28","current":-9.241453,"twenty":-33.918806,"median":-18.128877,"eighty":-8.893205,"marketCap":1448243940},{"date":"2024-04-05","current":-8.536193,"twenty":-33.589784,"median":-18.065512,"eighty":-8.838523,"marketCap":1336840560},{"date":"2024-04-12","current":-8.272823,"twenty":-33.35649,"median":-17.939408,"eighty":-8.727145,"marketCap":1296330240},{"date":"2024-04-19","current":-8.279892,"twenty":-33.174366,"median":-17.853668,"eighty":-8.605272,"marketCap":1296330240},{"date":"2024-04-26","current":-8.678713,"twenty":-33.059884,"median":-17.759229,"eighty":-8.524743,"marketCap":1357095720},{"date":"2024-05-03","current":-9.203206,"twenty":-32.801614,"median":-17.687796,"eighty":-8.477563,"marketCap":1438116360},{"date":"2024-05-10","current":-9.181408,"twenty":-32.632919,"median":-17.661614,"eighty":-8.477563,"marketCap":1438116360},{"date":"2024-05-17","current":-8.741635,"twenty":-32.551122,"median":-17.623136,"eighty":-8.477563,"marketCap":1367223300},{"date":"2024-05-24","current":-8.177535,"twenty":-32.325579,"median":-17.539325,"eighty":-8.449981,"marketCap":1276075080},{"date":"2024-05-31","current":-7.845046,"twenty":-32.033995,"median":-17.347726,"eighty":-8.385666,"marketCap":1225437180},{"date":"2024-06-07","current":-7.400377,"twenty":-31.809988,"median":-17.233543,"eighty":-8.298959,"marketCap":1154544120},{"date":"2024-06-14","current":-6.887364,"twenty":-31.578107,"median":-16.935206,"eighty":-8.273349,"marketCap":1073523480},{"date":"2024-06-21","current":-5.860029,"twenty":-31.347447,"median":-16.734241,"eighty":-8.218166,"marketCap":911482200},{"date":"2024-06-28","current":-5.211077,"twenty":-31.228256,"median":-16.576517,"eighty":-8.179208,"marketCap":810206400},{"date":"2024-07-05","current":-6.059193,"twenty":-31.009798,"median":-16.520848,"eighty":-8.127037,"marketCap":941864940},{"date":"2024-07-12","current":-6.115326,"twenty":-30.76933,"median":-16.436478,"eighty":-8.062904,"marketCap":951986880},{"date":"2024-07-19","current":-7.004141,"twenty":-30.557099,"median":-16.340035,"eighty":-8.028781,"marketCap":1090371240},{"date":"2024-07-26","current":-7.669327,"twenty":-30.166665,"median":-16.305518,"eighty":-7.995559,"marketCap":1198359750},{"date":"2024-08-02","current":-6.796557,"twenty":-29.911296,"median":-16.197141,"eighty":-7.891041,"marketCap":1061367400},{"date":"2024-08-09","current":-5.605068,"twenty":-29.68082,"median":-16.109649,"eighty":-7.860985,"marketCap":881135200},{"date":"2024-08-16","current":-5.284545,"twenty":-29.399025,"median":-16.004915,"eighty":-7.841452,"marketCap":831070700},{"date":"2024-08-23","current":-4.945296,"twenty":-29.313204,"median":-15.849402,"eighty":-7.79201,"marketCap":781006200},{"date":"2024-08-30","current":-5.353167,"twenty":-29.110493,"median":-15.769476,"eighty":-7.728882,"marketCap":851096500},{"date":"2024-09-06","current":-3.418622,"twenty":-28.890701,"median":-15.662682,"eighty":-7.666358,"marketCap":971251300},{"date":"2024-09-13","current":-3.060869,"twenty":-28.749884,"median":-15.561249,"eighty":-7.617596,"marketCap":867335190},{"date":"2024-09-20","current":-3.483773,"twenty":-28.561104,"median":-15.420271,"eighty":-7.598347,"marketCap":993090000},{"date":"2024-09-27","current":-3.760093,"twenty":-28.333146,"median":-15.365842,"eighty":-7.561653,"marketCap":1078304300},{"date":"2024-10-04","current":-4.747552,"twenty":-28.250282,"median":-15.319205,"eighty":-7.535461,"marketCap":1355299900},{"date":"2024-10-10","current":-4.708735,"twenty":-28.130154,"median":-15.28172,"eighty":-7.522101,"marketCap":1335514500},{"date":"2024-10-18","current":-4.628229,"twenty":-28.007466,"median":-15.211834,"eighty":-7.460943,"marketCap":1305836400},{"date":"2024-10-25","current":-4.787628,"twenty":-27.863809,"median":-15.071389,"eighty":-7.420411,"marketCap":1350724680},{"date":"2024-11-01","current":-4.888412,"twenty":-27.732043,"median":-15.043947,"eighty":-7.390073,"marketCap":1380088260},{"date":"2024-11-08","current":-5.393498,"twenty":-27.592224,"median":-14.969216,"eighty":-7.334181,"marketCap":1515776000},{"date":"2024-11-15","current":-5.694569,"twenty":-27.430791,"median":-14.889359,"eighty":-7.267767,"marketCap":1583441460},{"date":"2024-11-22","current":-6.224792,"twenty":-27.252497,"median":-14.784149,"eighty":-7.20416,"marketCap":1730056410},{"date":"2024-11-29","current":-5.401652,"twenty":-27.149392,"median":-14.63199,"eighty":-7.145452,"marketCap":1500274450},{"date":"2024-12-06","current":-6.462356,"twenty":-26.958966,"median":-14.415446,"eighty":-7.084264,"marketCap":1790650150},{"date":"2024-12-13","current":-7.525158,"twenty":-26.898699,"median":-14.328346,"eighty":-7.042598,"marketCap":2081025850},{"date":"2024-12-20","current":-9.773511,"twenty":-26.831826,"median":-14.194883,"eighty":-7.042598,"marketCap":2690814820},{"date":"2024-12-27","current":-10.308856,"twenty":-26.785545,"median":-13.98128,"eighty":-7.042598,"marketCap":2836002670},{"date":"2025-01-03","current":-11.036911,"twenty":-26.724476,"median":-13.876142,"eighty":-7.042598,"marketCap":3039265660},{"date":"2025-01-10","current":-10.090962,"twenty":-26.659448,"median":-13.738689,"eighty":-7.042598,"marketCap":2768248340},{"date":"2025-01-17","current":-13.505837,"twenty":-26.604626,"median":-13.644863,"eighty":-7.042598,"marketCap":3708038950},{"date":"2025-01-24","current":-14.258417,"twenty":-26.513964,"median":-13.644863,"eighty":-7.042598,"marketCap":3939189430},{"date":"2025-01-28","current":-14.045364,"twenty":-26.50266,"median":-13.646172,"eighty":-7.044971,"marketCap":3900664350},{"date":"2025-02-07","current":-14.613563,"twenty":-26.385453,"median":-13.643555,"eighty":-7.040226,"marketCap":4035502130},{"date":"2025-02-14","current":-14.027409,"twenty":-26.305488,"median":-13.643555,"eighty":-7.040226,"marketCap":3871770540},{"date":"2025-02-21","current":-20.966333,"twenty":-26.268748,"median":-13.643555,"eighty":-7.040226,"marketCap":5807655810},{"date":"2025-02-28","current":-23.024105,"twenty":-26.124527,"median":-13.643555,"eighty":-7.040226,"marketCap":6356638200},{"date":"2025-03-07","current":-23.948261,"twenty":-26.021583,"median":-13.637196,"eighty":-7.037853,"marketCap":6638331300},{"date":"2025-03-14","current":-27.478442,"twenty":-25.994745,"median":-13.637196,"eighty":-7.037853,"marketCap":7619649840},{"date":"2025-03-21","current":-28.63462,"twenty":-25.994745,"median":-13.637196,"eighty":-7.037853,"marketCap":7937135250},{"date":"2025-03-28","current":-22.254415,"twenty":-25.981622,"median":-13.637196,"eighty":-7.037853,"marketCap":7167473650},{"date":"2025-04-03","current":-19.455031,"twenty":-25.920491,"median":-13.637196,"eighty":-7.037853,"marketCap":6253500500},{"date":"2025-04-11","current":-16.143826,"twenty":-25.799935,"median":-13.637196,"eighty":-7.037853,"marketCap":5154695920},{"date":"2025-04-17","current":-14.844692,"twenty":-25.761244,"median":-13.643555,"eighty":-7.040226,"marketCap":4751255705},{"date":"2025-04-25","current":-18.855479,"twenty":-25.629177,"median":-13.630838,"eighty":-7.035481,"marketCap":6040177180},{"date":"2025-05-02","current":-19.624433,"twenty":-25.555188,"median":-13.637196,"eighty":-7.037853,"marketCap":6299866327},{"date":"2025-05-09","current":-19.687295,"twenty":-25.378575,"median":-13.630838,"eighty":-7.035481,"marketCap":6364413943},{"date":"2025-05-16","current":-16.189425,"twenty":-25.028984,"median":-13.630838,"eighty":-7.035481,"marketCap":5276397641},{"date":"2025-05-23","current":-19.381154,"twenty":-24.642413,"median":-13.630838,"eighty":-7.035481,"marketCap":6335528555},{"date":"2025-05-30","current":-22.492822,"twenty":-24.315979,"median":-13.630838,"eighty":-7.035481,"marketCap":7385031005},{"date":"2025-06-06","current":-22.37708,"twenty":-24.163622,"median":-13.630838,"eighty":-7.035481,"marketCap":7365774080},{"date":"2025-06-13","current":-27.602111,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":9089268930},{"date":"2025-06-20","current":-28.183664,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":9262581261},{"date":"2025-06-27","current":-25.15423,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":8290106513},{"date":"2025-07-04","current":-27.519363,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9070012004},{"date":"2025-07-11","current":-25.909492,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":8530818085},{"date":"2025-07-18","current":-34.00727,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":11188273831},{"date":"2025-07-25","current":-31.259636,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10321712175},{"date":"2025-08-01","current":-30.808479,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10109885992},{"date":"2025-08-08","current":-40.038892,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13171737178},{"date":"2025-08-15","current":-51.999696,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":17080893095},{"date":"2025-08-22","current":-50.820081,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14298267332},{"date":"2025-08-29","current":-48.026994,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13576938778},{"date":"2025-09-05","current":-47.125793,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13308972881},{"date":"2025-09-12","current":-39.078151,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":11056074414},{"date":"2025-09-19","current":-37.494834,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10600591060},{"date":"2025-09-26","current":-36.39561,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10263119060},{"date":"2025-10-03","current":-37.842129,"twenty":-24.207039,"median":-13.643555,"eighty":-7.040226,"marketCap":10696487426},{"date":"2025-10-10","current":-33.495493,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9454067526},{"date":"2025-10-17","current":-32.00426,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9026136568},{"date":"2025-10-24","current":-32.086576,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9052642598},{"date":"2025-10-31","current":-33.892495,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9576412188},{"date":"2025-11-07","current":-33.200765,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9375102324},{"date":"2025-11-14","current":-48.131606,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13629727156},{"date":"2025-11-21","current":-46.471802,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13153579483},{"date":"2025-11-28","current":-51.08762,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14512584301},{"date":"2025-12-05","current":-47.583674,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13540449468},{"date":"2025-12-12","current":-50.523029,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14403467126},{"date":"2025-12-19","current":-45.12776,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":12895666160},{"date":"2025-12-24","current":-43.638002,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":12508796175},{"date":"2026-01-02","current":-39.705675,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":11426392166},{"date":"2026-01-06","current":-41.075296,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":11842659840}],"updateTime":1767777502015},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01672\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2591364690","title":"Ascletis Pharma's Autoimmune Disease Drug Trial Shows Positive Topline Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2591364690","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591364690?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:35","pubTimestamp":1765802113,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said it recorded positive topline results from a phase I clinical trial of ASC50 in the US, a Monday filing with the Hong Kong bourse said.The study showed the drug exhibited favorable safety, tolerability, pharmacokinetics, and target engagement.The drug, for autoimmune and inflammatory diseases including psoriasis, has progressed into the next phase of clinical development in participants with mild to moderate plaque psoriasis.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01672","BK1574","BK1515","BK1161"],"gpt_icon":0},{"id":"2591611943","title":"Ascletis Announces Positive Topline Results From U.S. Phase I Study of Asc50, a Potential Best-in-Class Oral Small Molecule Il-17 Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2591611943","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591611943?lang=en_us&edition=fundamental","pubTime":"2025-12-15 17:00","pubTimestamp":1765789200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUA8DLPSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01672","BK1574","BK1515"],"gpt_icon":0},{"id":"2591611258","title":"Ascletis Pharma Inc - Asc50 Safe and Well Tolerated at All Dose Levels","url":"https://stock-news.laohu8.com/highlight/detail?id=2591611258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591611258?lang=en_us&edition=fundamental","pubTime":"2025-12-15 17:00","pubTimestamp":1765789200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUA8DLPSH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","BK1515","01672"],"gpt_icon":0},{"id":"1172177499","title":"ASCLETIS-B (01672): Positive Topline Results from US Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=1172177499","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172177499?lang=en_us&edition=fundamental","pubTime":"2025-12-15 16:56","pubTimestamp":1765788982,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced positive topline results from a randomized, double-blind, placebo-controlled Phase I clinical trial (NCT07024602) of ASC50 conducted in the US. The single ascending dose...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01477","BK1191","BK1515","01672","BK1574"],"gpt_icon":0},{"id":"2591611872","title":"Ascletis Pharma Reports Positive Phase I Results for Oral IL-17 Inhibitor ASC50","url":"https://stock-news.laohu8.com/highlight/detail?id=2591611872","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591611872?lang=en_us&edition=fundamental","pubTime":"2025-12-15 16:46","pubTimestamp":1765788393,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. has announced positive topline results from a randomized, double-blind, placebo-controlled Phase I clinical trial in the United States evaluating ASC50, a potential best-in-class oral small molecule IL-17 inhibitor. The study assessed the safety, tolerability, pharmacokinetics, and IL-17A target engagement profile of ASC50 in healthy participants who received single ascending doses ranging from 10 mg to 600 mg or placebo. The company stated that the elimination half-life of ASC50 ranged from 43 to 104 hours depending on the dose. Results from this study were announced on December 15, 2025. Ascletis will host a conference call to discuss the findings. The company noted that there is no guarantee of successful development, manufacturing, or commercialization of ASC50.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDLb46kyg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01672","BK1574","BK1515"],"gpt_icon":0},{"id":"1112317703","title":"Hong Kong Stocks Open Lower: Hang Seng Index Down 1%, Pharmaceutical Sector Leads Declines with ASCLETIS-B (01672) Dropping Over 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1112317703","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112317703?lang=en_us&edition=fundamental","pubTime":"2025-12-15 09:40","pubTimestamp":1765762834,"startTime":"0","endTime":"0","summary":"The Hang Seng Index opened 1% lower, while the Hang Seng Tech Index fell by 1.34%. In terms of sector performance, the assisted reproductive concept showed activity, with Jinxin Fertility, a stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f81ff915a0c110277ba56cf9ecd1a11a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","513600","BK1574","09939","MCHmain","159938","BK1161","01672","01477","BK4614","02833","HSImain","MHImain","HSI","BK1515","HHImain","YANG"],"gpt_icon":0},{"id":"1128212499","title":"ASCLETIS-B (01672) Repurchases 300,000 Shares for Approximately HK$4.37 Million on December 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1128212499","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128212499?lang=en_us&edition=fundamental","pubTime":"2025-12-12 18:24","pubTimestamp":1765535056,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that on December 12, 2025, the company repurchased 300,000 shares at a total cost of approximately HK$4.37 million.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","BK1515","BK1191","01672","01477"],"gpt_icon":0},{"id":"2590557700","title":"Ascletis Pharma Repurchases 300,000 Shares at HK$14.8 Each, Files Disclosure with HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2590557700","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590557700?lang=en_us&edition=fundamental","pubTime":"2025-12-12 18:20","pubTimestamp":1765534803,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. has filed a next day disclosure return with the Hong Kong Stock Exchange, reporting the repurchase of a total of 300,000 shares. The shares were repurchased at prices ranging from HKD 14.38 to HKD 14.80, with an aggregate price paid of HKD 4,373,830.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDLpC8G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1574","BK1515","BK1161"],"gpt_icon":0},{"id":"2590459300","title":"Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (Asc40), a First-in-Class Fasn Inhibitor for Acne Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2590459300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590459300?lang=en_us&edition=fundamental","pubTime":"2025-12-10 17:15","pubTimestamp":1765358100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUA1X77P6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","01672","BK1161","BK1574"],"gpt_icon":0},{"id":"1127214575","title":"ASCLETIS-B (01672): First-in-Class FASN Inhibitor Denifanstat (ASC40) NDA for Acne Treatment Accepted by China NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1127214575","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127214575?lang=en_us&edition=fundamental","pubTime":"2025-12-10 17:10","pubTimestamp":1765357824,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that the New Drug Application (NDA) for denifanstat (ASC40), a first-in-class, once-daily oral small-molecule fatty acid synthase (FASN) inhibitor targeting...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1515","BK1574","BK1161","BK1191","01672"],"gpt_icon":0},{"id":"2590030055","title":"China NMPA Accepts New Drug Application for Ascletis Pharma's Denifanstat for Acne Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2590030055","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590030055?lang=en_us&edition=fundamental","pubTime":"2025-12-10 17:02","pubTimestamp":1765357321,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. announced that the China National Medical Products Administration  has accepted its New Drug Application  for denifanstat , a first-in-class, once-daily oral small molecule fatty acid synthase  inhibitor, for the treatment of moderate-to-severe acne vulgaris. The NDA acceptance follows successful Phase III clinical trial results in which denifanstat met all primary and key secondary efficacy endpoints compared to placebo. The company recently completed a pre-NDA consultation with positive feedback from the NMPA. No grant or funding involving multiple organizations is mentioned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL83ydPK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01672","BK1574","BK1515"],"gpt_icon":0},{"id":"2590300371","title":"Ascletis Pharma Inc - Nmpa Acceptance of Nda for Denifanstat","url":"https://stock-news.laohu8.com/highlight/detail?id=2590300371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590300371?lang=en_us&edition=fundamental","pubTime":"2025-12-10 17:01","pubTimestamp":1765357301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XF14I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1161","BK1574","01672"],"gpt_icon":0},{"id":"2590971183","title":"Shares of Chinese Drugmaker Ascletis Rise on Weight-Loss Drug Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2590971183","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590971183?lang=en_us&edition=fundamental","pubTime":"2025-12-09 14:24","pubTimestamp":1765261440,"startTime":"0","endTime":"0","summary":"Shares of Ascletis Pharma surged Tuesday morning after the Chinese drugmaker said its weight-loss drug performed well in a study.The stock rose over 24% in Hong Kong to touch a four-month high before pulling back slightly. It is on track for its strongest day of gains since May, outperforming both the Hang Seng Index and the benchmark for biotech stocks, both of which were down more 1%.Ascletis's rally was sparked by positive results of a U.S. study of ASC30 tablets for obese and overweight patients.ASC30--Ascletis's contender in the GLP-1 class of weight-loss drugs like Ozempic and Wegovy--showed \"statistically significant and clinically meaningful\" weight loss in the phase II study, the China-based company said in a filing.The drug met key endpoints--clinical trial outcomes that help determine efficacy and safety--including reducing cholesterol and blood pressure, Ascletis said Monday.The firm plans to submit the data to the U.S. Food and Drug Administration as it looks to start phas","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Shares of Chinese Drugmaker Ascletis Rise on Weight-Loss Drug Results","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","01672","BK1574"],"gpt_icon":0},{"id":"1140883678","title":"Citi: Ascletis-B's ASC30 Phase IIa Data Further Demonstrates Best-in-Class Potential, Reiterates \"Buy/High Risk\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1140883678","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140883678?lang=en_us&edition=fundamental","pubTime":"2025-12-09 14:20","pubTimestamp":1765261226,"startTime":"0","endTime":"0","summary":"Citi released a research report stating that it expects a positive reaction in the share price of Ascletis-B (01672), reiterating a \"Buy/High Risk\" rating with a target price of HK$32. Citi believes...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU0980610538.SGD","LU1201861249.SGD","LU1244550577.SGD","LU0170899867.USD","LU1244550221.USD","LU0130102774.USD","LU0648001328.SGD","BK1515","LU1244550494.USD","LU1366192091.USD","LU0052756011.USD","BK4588","LU0098860793.USD","LU0128525689.USD","LU1162221912.USD","LU2417539215.USD","01672","BK4207","LU2360032135.SGD","LU0320765646.SGD","LU2236285917.USD","LU2462157665.USD","BK1191","IE00BSNM7G36.USD","01477","BK1574","BK4566","BK4504","LU2125154935.USD","LU1267930227.SGD","C","BK4559","LU1668664300.SGD","LU2456880835.USD","LU0106831901.USD","LU0130517989.USD","BK4534","LU0477156953.USD","LU1791807156.HKD","LU2125154778.USD","BK1161","LU0072461881.USD","LU0310800965.SGD","BK4585"],"gpt_icon":0},{"id":"1151245949","title":"Hong Kong Stocks Narrowly Fluctuate; ASCLETIS-B Surges Over 23% on Positive News","url":"https://stock-news.laohu8.com/highlight/detail?id=1151245949","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151245949?lang=en_us&edition=fundamental","pubTime":"2025-12-09 11:00","pubTimestamp":1765249240,"startTime":"0","endTime":"0","summary":"Hong Kong stocks opened slightly higher and traded within a narrow range in early trading on December 9. As of the latest update, the Hang Seng Index stood at 25,747.45 points, down 17.31 points or...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"eb673bcce88aebafcbc37fb491eb2df2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01477","BK1191","01672","BK1515","BK1161"],"gpt_icon":0},{"id":"1189609357","title":"HK Movers | Biomedical Stocks Jump With Ascletis Pharma up 21%, Sirnaomics up 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189609357","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189609357?lang=en_us&edition=fundamental","pubTime":"2025-12-09 10:07","pubTimestamp":1765246076,"startTime":"0","endTime":"0","summary":"Biomedical stocks jumped in Hong Kong. Ascletis Pharma rose 21%; Sirnaomics rose 11%; Joinn Laboratories rose 10%; WuXi XDC rose 5%; Pharmaron and WuXi Biologics rose 4%; WuXi AppTec rose 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"eb673bcce88aebafcbc37fb491eb2df2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127","02268","02257","01672","02359","03759","02269"],"gpt_icon":0},{"id":"1111095216","title":"HK Movers | Ascletis Pharma Surges as ASC30 Shows Positive Top-Line Results in 13-Week Phase 2 Obesity Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1111095216","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111095216?lang=en_us&edition=fundamental","pubTime":"2025-12-09 09:37","pubTimestamp":1765244220,"startTime":"0","endTime":"0","summary":"Ascletis Pharma surged 23.3% in Hong Kong.Ascletis Pharma announced that its 13-week Phase II study (NCT07002905) evaluating the oral small-molecule GLP-1 receptor (GLP-1R) agonist ASC30 for the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"gpt_icon":1},{"id":"2589903336","title":"Ascletis Pharma Inc - Asc30 Tablets Show Significant Dose-Dependent Weight Reductions","url":"https://stock-news.laohu8.com/highlight/detail?id=2589903336","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589903336?lang=en_us&edition=fundamental","pubTime":"2025-12-08 17:40","pubTimestamp":1765186817,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nFWN3XC0LM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1515","BK1161","01672"],"gpt_icon":0},{"id":"2589369013","title":"Ascletis' Oral Small Molecule Glp-1, Asc30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% With Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase Ii Study in Participants With Obesity or Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2589369013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589369013?lang=en_us&edition=fundamental","pubTime":"2025-12-08 17:40","pubTimestamp":1765186817,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nFWN3XC0LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01672","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"2589336188","title":"Ascletis Pharma Inc - No Hepatic Safety Signal Observed in Asc30 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2589336188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589336188?lang=en_us&edition=fundamental","pubTime":"2025-12-08 17:40","pubTimestamp":1765186817,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nFWN3XC0LM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1515","01672","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":198,"code":"91000000","status":"200"}]}}